Progress towards a public chemogenomic set for protein kinases and a call for contributions von Drewry, DH, Wells, CI, Andrews, DM, Angell, R, Al-Ali, H, Axtman, AD, Capuzzi, SJ, Elkins, JM, Ettmayer, P, Frederiksen, M, Gileadi, O, Gray, N, Hooper, A, Knapp, S, Laufer, S, Luecking, U, Michaelides, M, Mueller, S, Muratov, E, Denny, RA, Saikatendu, KS, Treiber, DK, Zuercher, WJ, Willson, TM

Volltext bestellen

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM von Bashore, Frances M, Katis, Vittorio L, Du, Yuhong, Sikdar, Arunima, Wang, Dongxue, Bradshaw, William J, Rygiel, Karolina A, Leisner, Tina M, Chalk, Rod, Mishra, Swati, Williams, C Andrew, Gileadi, Opher, Brennan, Paul E, Wiley, Jesse C, Gockley, Jake, Cary, Gregory A, Carter, Gregory W, Young, Jessica E, Pearce, Kenneth H, Fu, Haian, Axtman, Alison D

Volltext

Open drug discovery in Alzheimer's disease von Axtman, Alison D., Brennan, Paul E., Frappier‐Brinton, Tristan, Betarbet, Ranjita, Carter, Gregory W., Fu, Haian, Gileadi, Opher, Greenwood, Anna K., Leal, Karina, Longo, Frank M., Mangravite, Lara M., Edwards, Aled M., Levey, Allan I.

Volltext

Discovery of FERM domain protein–protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer’s disease von Du, Yuhong, Bradshaw, William J., Leisner, Tina M., Annor-Gyamfi, Joel K., Qian, Kun, Bashore, Frances M., Sikdar, Arunima, Nwogbo, Felix O., Ivanov, Andrey A., Frye, Stephen V., Gileadi, Opher, Brennan, Paul E., Levey, Allan I., Axtman, Alison D., Pearce, Kenneth H., Fu, Haian, Katis, Vittorio L.

Volltext

The Emory‐Sage‐SGC‐JAX TREAT‐AD Center: Target Enabling Packages for Alzheimer’s Disease Emerging Targets von Leal, Karina, Axtman, Alison D., Betarbet, Ranjita, Brennan, Paul E, Carter, Gregory W, Fu, Haian, Greenwood, Anna K, Longo, Frank M., Edwards, Aled M, Levey, Allan I., Center, Emory‐Sage‐SGC‐Jax TREAT‐AD

Volltext

The Emory‐Sage‐SGC TREAT‐AD Center: Tool and probe development for emerging targets in Alzheimer’s Disease von Leal, Karina, Axtman, Alison D., Betarbet, Ranjita, Brennan, Paul E, Carter, Gregory W, Frye, Stephen V., Fu, Haian, Greenwood, Anna K, Longo, Frank M., Pearce, Kenneth H., Edwards, Aled M, Levey, Allan I.

Volltext

The Emory‐Sage‐SGC TREAT‐AD Center: Tool development for novel targets in Alzheimer’s Disease von Leal, Karina, Axtman, Alison D., Betarbet, Ranjita, Brennan, Paul E, Carter, Gregory W, Fu, Haian, Greenwood, Anna K, Longo, Frank M., Edwards, Aled M, Levey, Allan I., Center, The Emory‐Sage‐SGC TREAT‐AD

Volltext

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM von Frances M Bashore, Vittorio L Katis, Yuhong Du, Arunima Sikdar, Dongxue Wang, William J Bradshaw, Karolina A Rygiel, Tina M Leisner, Rod Chalk, Swati Mishra, C Andrew Williams, Opher Gileadi, Paul E Brennan, Jesse C Wiley, Jake Gockley, Gregory A Cary, Gregory W Carter, Jessica E Young, Kenneth H Pearce, Haian Fu, Emory-Sage-SGC TREAT-AD Center, Alison D Axtman

Volltext